Vercirnon Sodium 

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVercirnon Sodium 
Drug Alias NameTraficet-EN维西孟vercirnon维赛农vercirnonum +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 9 antagonists
TargetsC-C chemokine receptor type 9
Therapy Area/IndicationsCeliac DiseaseCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[37] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesChemocentryx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcAmgen Inc
Active IndicationsN/A
Inactive IndicationsCeliac DiseaseCrohn DiseaseColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksKEGG